State Telehealth Prescribing Laws for GLP-1 Medications: 2026 Guide

During the COVID-19 pandemic, states dramatically loosened telehealth restrictions, allowing providers to prescribe medications — including controlled substances and weight loss drugs — through video and even phone-only consultations. As the public health emergency ended, states took divergent paths: Some states permanently codified pandemic-era telehealth flexibilities, making it easy for patients to access GLP-1 medications remotely. Others reverted to pre-pandemic rules requiring in-person visits, provider-patient relationship establishment, or additional documentation. A few states created new, specific regulations around telehealth prescribing of weight loss medications. The result is a confusing landscape where your ability to get a GLP-1 prescription via telehealth depends heavily on where you live.

Several states have adopted telehealth-friendly policies that make remote GLP-1 prescribing straightforward: These states generally allow providers to establish a patient-physician relationship via video visit, prescribe GLP-1 medications without requiring an initial in-person visit, and permit ongoing refills and dose adjustments through telehealth follow-ups. States in this category tend to have:

Some states maintain stricter requirements that can complicate telehealth GLP-1 prescribing: In-person visit requirements: A handful of states still require an initial in-person visit before a provider can prescribe certain medications via telehealth. This doesn't necessarily mean GLP-1s specifically, but some providers interpret these rules conservatively. Prescriber limitations: Some states restrict which types of providers can prescribe weight loss medications via telehealth. For example, nurse practitioners may not have independent prescribing authority in certain states. State-specific documentation: Several states require more extensive documentation for telehealth prescriptions, including detailed medical histories, lab work, and BMI verification. Controlled substance analogies: While GLP-1 medications aren't controlled substances, some states apply similar prescribing scrutiny to weight loss drugs, requiring in-person evaluations or specific DEA-related protocols.

Federal policy continues to shape the telehealth landscape: The CONNECT for Health Act, which has bipartisan support, would permanently remove geographic restrictions on Medicare telehealth services and expand the types of providers eligible to deliver telehealth care. The DEA has finalized rules for telehealth prescribing of controlled substances, and while GLP-1 medications aren't controlled substances, these rules set precedents that affect broader telehealth prescribing norms. CMS (Centers for Medicare & Medicaid Services) has expanded Medicare telehealth coverage, including for obesity management consultations, making it easier for Medicare beneficiaries to access GLP-1 prescriptions remotely. The FTC has also weighed in, warning states that overly restrictive telehealth regulations may constitute anticompetitive barriers to healthcare access.

Major telehealth weight loss providers handle the regulatory patchwork in several ways: Multi-state licensing: Top providers ensure their physicians and NPs are licensed in all states where they serve patients. This is the gold standard for compliance. State-specific protocols: Some providers maintain different intake processes for different states. Patients in restrictive states may need to complete lab work or an in-person visit before getting a telehealth prescription. Partnership models: Providers in restrictive states may partner with local clinics to fulfill in-person requirements, then manage ongoing care via telehealth. Asynchronous care: Some states allow asynchronous (non-live) telehealth for follow-up care, where patients submit questionnaires and providers review them without a live video call. When choosing a telehealth provider for GLP-1 medications, verify that they serve your state and ask about any state-specific requirements you'll need to meet.

Several states are actively updating their telehealth laws: Expansion trends: Most legislative activity is moving toward greater telehealth access, with multiple states considering bills to permanently expand telehealth prescribing authority. Weight loss-specific regulation: A few states are introducing specific guidelines for telehealth prescribing of anti-obesity medications, aimed at ensuring appropriate medical oversight without creating unnecessary barriers. Insurance parity enforcement: More states are enforcing telehealth parity laws, meaning insurers must cover telehealth visits at the same rate as in-person visits — removing a financial barrier for patients. Compounding pharmacy regulations: States are also updating rules around compounding pharmacies in light of the FDA's semaglutide crackdown, which indirectly affects what telehealth providers can offer.